Advanced methodology for in vivo magnetic resonance spectroscopy

Affiliations

¹ Department of Neurology, Hoglund Brain Imaging Center, University of Kansas Medical Center, Kansas City, Kansas, USA.
² Department of Radiology, Nuclear Medicine, and Neuroradiology and Department of Biomedical Research, University Bern, Bern, Switzerland.

Editorial

In-Young Choi et al. NMR Biomed. 2021 May.

. 2021 May;34(5):e4504.

doi: 10.1002/nbm.4504. Epub 2021 Mar 11.

¹ Department of Neurology, Hoglund Brain Imaging Center, University of Kansas Medical Center, Kansas City, Kansas, USA.
² Department of Radiology, Nuclear Medicine, and Neuroradiology and Department of Biomedical Research, University Bern, Bern, Switzerland.

No abstract available

References

1. Oz G, Alger JR, Barker PB, et al. Clinical proton MR spectroscopy in central nervous system disorders. Radiology. 2014;270(3):658-679.
1. Wilson M, Andronesi O, Barker PB, et al. Methodological consensus on clinical proton MRS of the brain: review and recommendations. Magn Reson Med. 2019;82(2):527-550.
1. Maudsley AA, Andronesi OC, Barker PB, et al. Advanced magnetic resonance spectroscopic neuroimaging: experts' consensus recommendations. NMR Biomed. 2020;e4309.
1. Kreis R, Boer V, Choi IY, et al. Terminology and concepts for the characterization of in vivo MR spectroscopy methods and MR spectra: background and experts' consensus recommendations. NMR Biomed. 2020;e4347.
1. Lin A, Andronesi O, Bogner W, et al. Minimum reporting standards for in vivo magnetic resonance spectroscopy (MRSinMRS): experts' consensus recommendations. NMR Biomed. 2021;e4484.